Literature DB >> 12174031

Treatment of upper respiratory tract infections--a comparative study of dispensing and non-dispensing doctors.

B Trap1, E H Hansen.   

Abstract

BACKGROUND: The reported results are part of an overall evaluation of drug management by dispensing (DDs) and non-dispensing doctors (NDDs). This study focuses on appropriate prescription. Other studies assess good pharmacy practice. Whereas rationality of prescription has been studied based on simple indicators, appropriate prescription in relation to diagnoses and symptoms has not been assessed.
OBJECTIVE: To analyse prescriptions by DDs and NDDs for patients diagnosed with upper respiratory tract infection.
METHODS: Cohort study of 28 private sector DDs and 28 NDDs, using retrospective registry data from a mean of 14.5 and 16.0 patient records per practice, respectively. OUTCOME MEASURES: Drug choice, frequency of the drugs being used, use of antibiotics and dosages for respiratory infections where antibiotics are/are not justified.
RESULTS: DDs were associated with a greater number of drugs per encounter (P < = 0.001), a greater number of injections (P = < 0.002), more use of analgesic drugs (P = < 0.001), cough and cold preparations (P < 0.001) and psycholeptics (P = < 0.03). The choice of antibiotics for upper respiratory tract infection (URTI) was assessed as rational, although different for the two practices, but both practices over-prescribe antibiotics frequently. Dispensing doctors frequently prescribe sub-curative dosages and fewer curative dosages (P = < 0.001), compared with NDDs.
CONCLUSION: Irrational prescription for URTI is widespread by both dispensing doctors and to a lesser extent, by NDDs. Symptomatic treatments with 'a drug for each symptom' was common, particularly by the DDs. There was also over-prescription of antibiotics and use of sub-therapetitic dosages. This poly-pharmacy, poses a safety risk, a risk of development of resistance and, unnecessarily costly treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12174031     DOI: 10.1046/j.1365-2710.2002.00425.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  6 in total

1.  Prescribing habits of general practitioners in the treatment of childhood respiratory-tract infections.

Authors:  Ahmet Akici; Sibel Kalaça; M Umit Uğurlu; Sule Oktay
Journal:  Eur J Clin Pharmacol       Date:  2004-03-31       Impact factor: 2.953

2.  Knowledge, attitudes and practices towards antibiotic use in upper respiratory tract infections among patients seeking primary health care in Singapore.

Authors:  Darius Shaw Teng Pan; Joyce Huixin Huang; Magdalene Hui Min Lee; Yue Yu; Mark I-Cheng Chen; Ee Hui Goh; Lili Jiang; Joash Wen Chen Chong; Yee Sin Leo; Tau Hong Lee; Chia Siong Wong; Victor Weng Keong Loh; Adrian Zhongxian Poh; Tat Yean Tham; Wei Mon Wong; Fong Seng Lim
Journal:  BMC Fam Pract       Date:  2016-11-03       Impact factor: 2.497

3.  Identifying the most effective essential medicines policies for quality use of medicines: A replicability study using three World Health Organisation data-sets.

Authors:  Kathleen Anne Holloway; Verica Ivanovska; Solaiappan Manikandan; Mathaiyan Jayanthi; Anbarasan Mohan; Gilles Forte; David Henry
Journal:  PLoS One       Date:  2020-02-06       Impact factor: 3.240

4.  Comparison of paracetamol and diclofenac prescribing preferences for adults in primary care.

Authors:  Dilara Bayram; Volkan Aydin; Abdullah Sanli; Mustafa Naci Abanoz; Busra Sibic; Sedat Pala; Omer Atac; Ahmet Akici
Journal:  Prim Health Care Res Dev       Date:  2021-12-02       Impact factor: 1.458

5.  Patient presentation and physician management of upper respiratory tract infections: a retrospective review of over 5 million primary clinic consultations in Hong Kong.

Authors:  Kenny Kung; Carmen Ka Man Wong; Samuel Yeung Shan Wong; Augustine Lam; Christy Ka Yan Chan; Sian Griffiths; Chris Butler
Journal:  BMC Fam Pract       Date:  2014-05-13       Impact factor: 2.497

6.  WHO essential medicines policies and use in developing and transitional countries: an analysis of reported policy implementation and medicines use surveys.

Authors:  Kathleen Anne Holloway; David Henry
Journal:  PLoS Med       Date:  2014-09-16       Impact factor: 11.069

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.